A new national poll reveals that 47% of registered voters believe doctors should not be allowed to prescribe puberty blockers to children under any circumstances. The survey, conducted by The Center Square and Noble Predictive Insights, underscores the growing national divide over medical interventions for minors, especially those related to gender identity.
Only 29% of voters said doctors should be permitted to prescribe puberty blockers to minors with parental consent. That number drops to just 10% if parents are not involved. An additional 14% of respondents said they were unsure.
The poll highlights deep partisan differences. Among Democrats, 41% support allowing puberty blockers with parental approval, while only 16% of Republicans agree. A substantial 68% of Republicans said doctors should never be permitted to prescribe such drugs to minors, regardless of parental opinion.
Though widely discussed in the context of gender transition, puberty blockers are also used to treat conditions such as precocious puberty and growth hormone deficiencies. Nonetheless, many states have moved to restrict the use of these medications in minors, particularly when tied to transgender care.
The American Medical Association and other leading medical groups continue to support puberty blockers as a treatment option. Still, critics argue that the long-term effects are unknown and that minors are too young to make life-altering decisions.
President Donald Trump signed an executive order on his first day in office restricting transgender-related drugs and surgeries for minors. Several states have implemented bans, many of which are now being challenged in court. The U.S. Supreme Court is currently reviewing legal challenges to these bans.
The poll surveyed 2,527 registered voters between April 15–18, 2025, with a margin of error of ±2.0%.
